New Research Article!
Treatable metabolic and inflammatory abnormalities in Post COVID Syndrome (PCS) define the transcriptomic basis for persistent symptoms: Lessons from CIRS
Authors:
Shoemaker R, McMahon S, Heyman A, Lark D, van der Westhuizen M, Ryan J
ABSTRACT Within three months of the onset of acute SARS-CoV-2 (COVID-19) infections, new and persistent symptoms were noted in survivors. While the world’s medical and research communities focus on saving lives following COVID-19 infection, a relentless march of new cases of Post-COVID Syndrome (PCS) continuesto spread around the globe as a second COVID-related pandemic. Efforts to define the physiology of PCS, a multisystem, multisymptom illness, continue without success, in part due to the markedly different case presentations.
Using a transcriptomic assessment of persistently ill cases of PCS, we show the presence of (i) molecular hypometabolism (MHM) and proliferative physiology; (ii) elevated levels of ribosomal stress responses and a concomitant increase in gene activation of TGFBR; and (iii) common co-expression of CD14 and Toll Receptor 4, correlated to exposure of amplified microbial growth in a water-damaged environment, specifically Actinobacteria and endotoxin, respectively, compared to recovered PCS cases. Total symptom scores and visual contrast sensitivity (VCS) results showed statistically significant differences.
The data reported here supports the concept that PCS occurs in patients with additional environmental exposures and enhanced TGF signaling. In a strikingly similar condition called Chronic Inflammatory Response Syndrome (CIRS), named in 2010, the transcriptomic abnormalities were identified to respond to treatment with FDA-cleared medications, with salutary benefits for affected cases. Though sparsely reported, PCS cases share proteomic findings with CIRS. While additional studies are indicated, a new approach to the treatment of PCS is suggested.
Featured Resources
Shoemaker Protocol™ Quick Start:
The 3 initial steps to determine if mold is affecting you One of the most common questions we hear is, “how do I know if I have mold illness?” Rest assured, if you’re asking this question, you’ve come to the right place.
Joint Surviving Mold/ CIRSx Conference May 17-19, 2024 in Frisco, TX
With a world-renowned lineup of speakers including keynote Ritchie Shoemaker, MD, from May 17th-19th.
Dr. Scott McMahon & Dr. Ritchie Shoemaker on Episode 415 of the Dr. Jordan B. Peterson Podcast
Dr. Jordan B. Peterson speaks with Dr. Scott McMahon and Dr. Ritchie Shoemaker. They discuss their potentially groundbreaking research into CIRS, or Chronic Inflammatory Response Syndrome.
Guidelines for Preventing Exposure (through the holidays and always)
It does take diligence and some proactive planning, but preventing mold exposure and thriving with CIRS is doable and possible, even through the busy holiday season. There are apparent consistencies, practices, and behaviors among those who thrive with CIR...
The Heart of CIRS Podcast with Melanie Joy Pensak
Heartfelt conversations with folks recovering from CIRS & with those special people serving the CIRS community (Chronic Inflammatory Response Syndrome).
Related Resources
- Surviving Mold Podcast -Episode 1 with Dr. Karen Johnson
- Moldy: A Conversation with Ritchie Shoemaker
- MOLDY, the Movie: Rock and Roll Teaches us about Wet Buildings
- State of the Art Conference of CIRS-2 planning is picking up steam!
- Dr. Shoemaker appearing at Australian Conferences
- My Name Is Erik Johnson
- FAQ Video #4: Exercises and Capillary Hypoperfusion